In this study, we demonstrated that CFB upregulation enhanced alternative complement pathway activation in the glomeruli during the development of DKD in both patients and mouse models, which was correlated with mTORC1 activation and diabetic glomerulosclerosis. The gene discussed is CFB; the disease is diabetic kidney disease.